Diffusion Pharmaceuticals Inc.
DFFN
$0.41
Change (1 day)
$14.37
Year High
$4.14
Year Low
Categories
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
Revenue of Diffusion Pharmaceuticals Inc. (DFFN)
Revenue in 2022 (TTM): $
According to Diffusion Pharmaceuticals Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Diffusion Pharmaceuticals Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2022 | $ | $ | $-15,972,180 | $-15,591,428 | $-15,210,676 |
| 2021 | $ | $ | $-7,305,691 | $-24,539,620 | $-24,095,727 |
| 2020 | $ | $ | $-15,871,776 | $-15,860,687 | $-14,185,306 |
| 2019 | $ | $ | $11.55 B | $-11,466,494 | $-11,799,379 |
| 2018 | $ | $ | $18.96 M | $-18,807,099 | $-18,369,810 |
| 2017 | $ | $ | $11.35 M | $-2,420,203 | $-1,364,518 |
| 2016 | $ | $ | $18.37 M | $-18,401,415 | $-18,036,619 |
| 2015 | $ | $ | $-1,661,781 | $-23,820,675 | $-23,820,675 |
| 2014 | $ | $ | $-9,659,598 | $-17,169,708 | $-14,352,824 |
| 2013 | $71.67 K | $-17,720 | $-14,100,209 | $-2,457,949 | $-2,464,350 |
| 2012 | $374.54 K | $138.74 K | $-7,613,183 | $-6,849,816 | $-6,849,815 |
| 2011 | $570.48 K | $-1,738,134 | $-16,359,539,000 | $-15,837,168 | $-15,837,168 |
| 2010 | $40.19 K | $-170,204 | $-7,628,544 | $-8,409,605 | $-8,409,605 |
| 2009 | $ | $-747,168,000 | $-3,542,063,000 | $-3,918,986 | $-3,401,098 |
| 2008 | $40.19 K | $15.51 K | $-1,019,556 | $-906,778 | $-1,093,267 |
| 2007 | $ | $ | $-55,800 | $-60,762 | $-60,762 |
| 2006 | $ | $ | $-41,900 | $-48,096 | $-48,096 |
| 2005 | $ | $ | $-92,200 | $-94,863 | $-94,863 |
| 2004 | $2.56 M | $30 K | $-2,780,000 | $-2,710,000 | $-2,850,000 |
| 1999 | $26.94 M | $48.06 K | $-6,934,193 | $-6,449,984 | $-8,060,282 |
| 1998 | $27.9 M | $4.3 M | $800 K | $ | $200 K |